ORTEXORTEX News
Tracking ATI? Get live short interest, options flow, and signals on ORTEX.Sign up free →
AT
Earnings PreviewATI

ATI Shares Drop 15% in a Week While Short Interest Hits a Year High

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 26 Oct 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

ATI fell 15.5% over the past week to close at $156.88, roughly double the median decline of 6.8% posted by its closest aerospace and specialty materials peers. Short interest climbed 34% over the past month to 3.5% of the free float, the highest reading in at least a year, with the bulk of that build concentrated in the first two weeks of October.

The peer gap is worth isolating. CRS dropped 24.5% on the week, making ATI's move look contained by comparison, but VSEC fell 13.4% and most other correlated names shed 4% to 8%. The breadth of weakness across aerospace sub-tiers suggests a sector-level repricing rather than a company-specific shock, yet ATI's decline sits near the top of the range. That divergence from a stock that was up more than 80% year-to-date as recently as August makes the price action harder to dismiss as noise.

The debt on the short side, however, is thin. Borrow is easy to source, availability is essentially unconstrained, and the cost to borrow has declined 25% over the past week to 0.30%. The ORTEX short score is a modest 34, sitting in the 44th percentile of its sector. Options positioning has actually turned less defensive into the print: the put/call ratio is running at 0.61, more than a standard deviation below its 20-day average of 0.78, close to the 52-week low of 0.23. That tilt toward calls is unusual given the share price performance. Taken together, the lending and options data do not point to a coordinated short thesis, the short interest build looks more opportunistic than structural.

The analyst community has been trimming targets without abandoning the stock. Keybanc cut its price target from $258 to $228 on October 8, and Wells Fargo moved from $275 to $240 on September 30, both while holding Overweight ratings. The consensus mean target of $249 implies roughly 59% upside from Friday's close, a gap that reflects how far and how fast the stock has fallen from the levels at which August estimates were set. The bull case rests on ATI's specialty energy and aerospace materials franchises, where mid-teens 2026 growth projections were set after a strong Q2 print that sent the stock up 11% in a day. Bears point to deteriorating non-aerospace and defense end markets, a valuation multiple that has re-rated lower relative to peers like CRS over the past 30 days, and a PE that has compressed roughly five turns over the same period even as earnings estimates held up.

Insider activity complicates the picture in a specific way. CEO Kimberly Fields sold approximately $5.4 million of stock in August under a pre-arranged 10b5-1 plan, and Senior VP Timothy Harris sold a further $15.2 million across September in a series of plan-driven transactions. All trades were conducted under 10b5-1 programs, which limits their informational value, but net insider sales over the past 90 days total around $36.3 million. No open-market purchases appear in the record over that period.

The October 29 print will test whether the Q3 numbers support the earnings trajectory that underpinned the stock's 80% advance into late summer, or whether the sector-wide pressure visible in this week's peer performance has reached ATI's own order book.

Stocks in this article

See the live data behind this article on ORTEX.

Open ATI on ORTEX →

How this article was generated

Generated
26 Oct 2026, 04:03
Data as of
26 Oct 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.